I am certain that it was Jack’s selflessness—his orientation to others and ability to conceive of how much better things could be—that accounted for the passion he brought to his research and writing and everyday conversation.

AEI scholars are available to comment on health care vote developments over the weekend.

Congress is in the process of rewriting the United States' patent laws. Scientific and technological changes in virtually all markets have dramatically altered the patent system itself. Reacting to fears that patents and patent litigation could retard rather than support technological progress, legislators are poised to take action with the...

AEI scholars provide insights on the impact of proposed health reform, as well as guidelines for fixing the U.S. health care system.

How will new prescription label requirements affect pharmaceutical companies?

A recent court decision has been widely applauded as a pathway to abolishing human gene patents. But a closer look shows that getting rid of gene patents would probably be a big mistake.

The development of antivirals for pandemic flu provides important insights into the pharmaceutical industry's ability to advance public health.

Almost all pharmaceuticals are purchased by third parties (insurance or government) through the use of reimbursements. Yet, as University of Chicago health economists Anupam B. Jena and Tomas J. Philipson demonstrate in their new book, Innovation and Technology Adoption in Health Care Markets (AEI Press, August 2008), reimbursement levels based...